Patents by Inventor Domenico Fanara

Domenico Fanara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Compositions Comprising Levocetirizine
    Publication number: 20210251984
    Abstract: The present invention relates to a pharmaceutical composition comprising levocetirizine. The invention relates specifically to a dry syrup formulation.
    Type: Application
    Filed: March 3, 2021
    Publication date: August 19, 2021
    Inventors: Domenico Fanara, Jonathan Goole, Michel Deleers
  • Pharmaceutical Compositions Comprising Levocetirizine
    Publication number: 20200297718
    Abstract: Disclosed are pharmaceutical compositions comprising levocetirizine.
    Type: Application
    Filed: January 23, 2020
    Publication date: September 24, 2020
    Inventors: Domenico Fanara, Jonathan Goole, Michel Deleers
  • Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
    Patent number: 10729653
    Abstract: The present invention relates to an immediate release formulation of pharmaceutical compounds.
    Type: Grant
    Filed: January 27, 2010
    Date of Patent: August 4, 2020
    Assignee: UCB BIOPHARMA SRL
    Inventors: Serge Cuypers, Monique Berwaer, Domenico Fanara, Valery Barillaro
  • Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivative
    Publication number: 20200085754
    Abstract: The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: July 12, 2019
    Publication date: March 19, 2020
    Inventors: Domenico Fanara, Frederic Eeckman, Monique Berwaer
  • Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivative
    Publication number: 20190142759
    Abstract: The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: January 7, 2019
    Publication date: May 16, 2019
    Inventors: Domenico Fanara, Frederic Eeckman, Monique Berwaer
  • Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivative
    Patent number: 10172805
    Abstract: The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Grant
    Filed: November 17, 2009
    Date of Patent: January 8, 2019
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Domenico Fanara, Frédéric Eeckman, Monique Berwaer
  • Pharmaceutical Compositions Comprising Levocetirizine
    Publication number: 20170105988
    Abstract: The present invention relates to a pharmaceutical composition comprising levocetirizine. The invention relates specifically to a dry syrup formulation.
    Type: Application
    Filed: March 26, 2015
    Publication date: April 20, 2017
    Inventors: Domenico Fanara, Jonathan Goole, Michel Deleers
  • Formulations
    Patent number: 8946229
    Abstract: The present invention relates to pharmaceutical compositions for oral administration of active compounds.
    Type: Grant
    Filed: August 28, 2008
    Date of Patent: February 3, 2015
    Assignee: UCB, Inc.
    Inventors: Domenico Fanara, Monique Berwaer, Anthony Guichaux, Michel Deleers
  • Pharmaceutical composition of piperazine derivatives
    Patent number: 8633194
    Abstract: The present invention relates to a liquid composition containing an active substance belonging to the family of substituted benzhydryl piperazines with reduced amounts of preservatives.
    Type: Grant
    Filed: July 6, 2005
    Date of Patent: January 21, 2014
    Assignee: UCB Pharma, S.A.
    Inventors: Domenico Fanara, Jean Scouvart, Claire Poulain, Michel Deleers
  • Pharmaceutical compositions comprising Brivaracetam
    Patent number: 8563036
    Abstract: The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Grant
    Filed: February 5, 2010
    Date of Patent: October 22, 2013
    Assignee: UCB Pharma, S.A.
    Inventors: Frédéric Eeckman, Domenico Fanara, Monique Berwaer
  • Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate
    Patent number: 8460712
    Abstract: The present invention relates to a pharmaceutical composition comprising Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation made of granules containing the active ingredient in their inner core.
    Type: Grant
    Filed: November 17, 2009
    Date of Patent: June 11, 2013
    Assignee: UCB Pharma, S.A.
    Inventors: Domenico Fanara, Frédéric Eeckman, Monique Berwaer
  • Pharmaceutical compositions comprising brivaracetam
    Patent number: 8435564
    Abstract: The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: May 7, 2013
    Assignee: UCB Pharma, S.A.
    Inventors: Frederic Eeckman, Monique Berwaer, Domenico Fanara
  • Pharmaceutical Compositions Comprising Brivaracetam
    Publication number: 20120040006
    Abstract: The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: February 5, 2010
    Publication date: February 16, 2012
    Applicant: UCB PHARMA, S.A.
    Inventors: Frédéric Eeckman, Domenico Fanara, Monique Berwaer
  • FORMULATIONS
    Publication number: 20120010218
    Abstract: The present invention relates to pharmaceutical compositions for oral administration of active compounds.
    Type: Application
    Filed: September 23, 2011
    Publication date: January 12, 2012
    Inventors: Domenico Fanara, Monique Berwaer, Anthony Guichaux, Michel Deleers
  • Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives
    Publication number: 20110281929
    Abstract: The present invention relates to an immediate release formulation of pharmaceutical compounds.
    Type: Application
    Filed: January 27, 2010
    Publication date: November 17, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Serge Cuypers, Monique Berwaer, Domenico Fanara, Valery Barillaro
  • Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives
    Publication number: 20110275693
    Abstract: The present invention relates to an immediate release formulation of pharmaceutical compounds.
    Type: Application
    Filed: January 27, 2010
    Publication date: November 10, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Serge Cuypers, Monique Berwaer, Domenico Fanara, Valery Barillaro, Martine Larbanoix, Frederic Dargelas
  • Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivate
    Publication number: 20110274762
    Abstract: The present invention relates to a pharmaceutical composition comprising Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation made of granules containing the active ingredient in their inner core.
    Type: Application
    Filed: November 17, 2009
    Publication date: November 10, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Domenico Fanara, Frederic Eeckman, Monique Berwaer
  • Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivative
    Publication number: 20110250282
    Abstract: The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: November 17, 2009
    Publication date: October 13, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Domenico Fanara, Frédéric Eeckman, Monique Berwaer
  • Pharmaceutical Compositions Comprising Brivaracetam
    Publication number: 20110091547
    Abstract: The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: May 28, 2009
    Publication date: April 21, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Frederic Eeckman, Monique Berwaer, Domenico Fanara, Domenico Fanara
  • Novel Pharmaceutical Compositions Comprising Levetiracetam
    Publication number: 20110027359
    Abstract: The present invention relates to a pharmaceutical composition comprising levetiracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: March 10, 2010
    Publication date: February 3, 2011
    Applicant: UCB, S.A.
    Inventors: Caroline Goffin, Monique Berwaer, Michaël Boonen, Michel Deleers, Domenico Fanara